CME Group (CME) PT Raised to $300 at TD Cowen on 'Broadening Growth Drivers'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts CME Hot Sheet
Rating Summary:
14 Buy, 11 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Join SI Premium – FREE
TD Cowen analyst Bill Katz raised the price target on CME Group (NASDAQ: CME) to $300.00 (from $292.00) while maintaining a Buy rating.
The analyst commented: "Broadening Growth Drivers - Management Meeting Takes; We affirm our Buy rating, raise our '26-27E adj. EPS and lift our 12M price target $8 to $300 post TD Cowen-sponsored investor meetings with senior management, truing up for 3Q ADV/ stronger outlook and higher repurchase. Concurrently, we lift our preference on CME among our Exchanges ranks.
Affirm Buy; lift 12M price target $8 to $300, reflecting higher earnings expectations. We move CME up our relative ranks w/in Exchanges."
You May Also Be Interested In
- Evercore ISI Removes CDW Corporation (CDW) from TAP Outperform List
- Dave Inc. (DAVE) Tops Q3 EPS by 31c; offers guidance
- Tronox (TROX) Misses Q3 EPS by 14c, Misses on Revenue; Offers Guidance
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
Cowen & Co, Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
